bbfh2027 finalists
Published On: November 13, 2026Categories: Entrepreneurial, Medical Device, Product Design

On 12 November, eight founders showcased their ventures with the Australian MedTech community at the Building Better Futures for Health (BBFH) Challenge 2027 Semi-Finalist Showcase in Sydney.

Three teams came away with a place in the Grand Finals: Sonorus, ArthroLase and FivepHusion. They join US Finalist Octin Health on stage at the Medical Technology Association of Australia (MTAA) MedTech Conference on 3 March 2027.

Eight teams, three places

Every semi-finalist brought a clear clinical problem and a credible plan to solve it. We thank each of them for the work they put in:

• Proseek Bio (Dr Michelle Hill): OC-Triage, a blood test that helps clinicians tell ovarian cancer apart from benign conditions, so high-risk women reach specialists sooner.

• Sonorus (Dr Julie Dao): SONO1, a low-cost chest sensor that lets health workers in remote communities detect rheumatic heart disease without a specialist.

• NOYA Biomedical (Dr Farin Yazdan Parast): the Sperm Syringe, a single-use device that gives in vitro fertilisation (IVF) labs a simpler, standardised way to select sperm in 15 minutes.

• Nuro Medical (Dr Wade McFarlane): NuroUno, a wearable that people with fibromyalgia, migraine and nerve pain use at home to reduce pain without surgery or drugs.

• FivepHusion (Dr Christian Toouli): ResectAssist, an implant that delivers chemotherapy directly into pancreatic tumours to shrink them until surgery becomes possible.

• Gifts Inc. (Dr Jun Ogasawara): a wearable foetal ultrasound that midwives and rural clinicians can use without a sonographer, aiming to catch foetal growth restriction earlier.

• ArthroLase (Brett Robertson): HAiLO, a robotic laser that replaces the bone saw in knee replacement surgery and preserves healthy tissue.

• Neurospheric (Dr Roshan De Silva): Neuro-Ops, a robotic neurosurgery system with a flexible probe that curves around critical brain structures.

Why our Finalists stood out

  • Sonorus. Rheumatic heart disease is treatable with penicillin, but only if it’s caught before it permanently damages the heart. In remote communities without a specialist, it often isn’t. Dr Julie Dao and the Sonorus team are developing SONO1, a low-cost, AI-enabled chest sensor that puts that early detection in the hands of local health workers.

  • ArthroLase. Knee replacement surgery still relies on the bone saw. Brett Robertson and the ArthroLase team are replacing it with HAiLO, a robotic laser guided by its own navigation and visualisation system. Surgeons can remove bone selectively, preserve healthy tissue and fit implants without cement.

  • FivepHusion. Surgery is the only potentially curative treatment for pancreatic cancer, but many tumours are inoperable when they’re found. Dr Christian Toouli and the FivepHusion team are developing ResectAssist, an implant that delivers chemotherapy directly into the tumour. The aim is to shrink it until surgery becomes possible, while reducing the side effects of standard chemotherapy.

BBFH 2027 drew 66 applications, more than double last year, and the most competitive field we’ve seen. That raised the bar. A strong idea with real potential for patients, clinicians and health systems was no longer enough on its own. The judges wanted evidence of clinical and market need, and a viable path to market. Every applicant deserves credit for working towards that standard. Our semi-finalists met it, but our 3 Australian Finalists and 1 US Finalist met it most convincingly.

The road to the Grand Finals

For the first time, the Grand Finals will bring together Finalists from Australia and the US. The four teams will pitch at the MTAA MedTech Conference for AU$30,000 in IDE Group services across strategy, product development, human factors engineering and manufacturing. A People’s Choice Award of AU$10,000 in services is also on offer.

Between now and March, each Finalist will work to sharpen their pitch and their path to market.

Thank you

Thank you to our judges Dr Alan Taylor, Anne O’Neill, Mick Brooks, Oona Reardon and Jeff Reid, to our collaborators MTAA and MedTech Compass, and to everyone who applied, pitched or came along on the night.

Follow the Finalists on the road to Sydney at ide.group/bbfh-challenge.

Contact for Media Inquires:

Matt Allison
Marketing Manager
IDE Group
Phone: +61 2 9647 2660
Address: 701-703 Paramatta Rd,
Leichhardt, NSW 2040. Australia
Email: partnering@ide.group

Share this article
Post
BBFH 2027 FinalistsOctin Health named US Finalist for BBFH 2027